Q4FY21 Result Update - Apollo Hospitals - ICICI Direct

Apollo Hospital's Q4FY21 revenues came in at Rs. 2868 crore (I-direct estimate: Rs. 2857.7 crore). They are not comparable YoY due to restructuring of the retail pharmacy business to pharmacy distribution (post demerger). On the other hand, the hospital segment grew 10.1% YoY to Rs. 1443 crore vs. I-direct estimate of Rs. 1490 crore. Pharmacy distribution segment revenues came in at Rs. 1118.7 crore. EBITDA margins improved 135 bps YoY to 14.4% mainly due to lower staff cost, which likely stems from restructuring of retail pharmacy to pharmacy distribution. Subsequently, EBITDA grew 8.4% YoY to Rs. 411.8 crore). Adjusted PAT for the quarter grew 106.3% YoY, 15.3% QoQ to Rs. 167.9 crore. Delta vis-à-vis EBITDA was mainly due to lower depreciation, interest cost and higher other income.

For details, click on the link below: Link to the report

Shares of APOLLO HOSPITALS ENTERPRISE LTD. was last trading in BSE at Rs.3438.7 as compared to the previous close of Rs. 3203.7. The total number of shares traded during the day was 167385 in over 14759 trades.

The stock hit an intraday high of Rs. 3464.95 and intraday low of 3200. The net turnover during the day was Rs. 567411028.

Source : Equity Bulls

Keywords